...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Disease X

Fuzzy you are right about that - the facts speak for themselves. The well is dry. A Zenith bail out appears to be the most likely funding source for RVX advancement.

So we wait on trial results. Next hurdle is the Hepa debenture. Last years extension came around this time. What will be the verdict this year? 

Share
New Message
Please login to post a reply